Stem Cells a Central Topic at 5th Modern Drug Discovery & Development Conference

Monrovia, California (PressExposure) August 19, 2009 -- Stem Cells to be a Central Track at GTCbio's 5th Annual Modern Drug Discovery & Development Conference held on October 14-16, 2009 in San Diego, CA

With the lift of the federal ban on stem cell research, new and exciting research opportunities and funding sources will arise. The 5th Annual Modern Drug Discovery & Development Summit presents its attendants with information regarding cutting-edge developments in all areas of stem cell research including the biology, medicine, applications, regulations, and business of stem cells. Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, FDA and NIH policies regarding funding for stem cell research, and private funding from the pharmaceutical industry will be addressed. M3D is an opportunity for members of the biotech and pharmaceutical professional community to learn about the current state of stem cell research, network with high-level executives, and explore the future of stem cell R&D together.

About GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.

Press Release Source:

Press Release Submitted On: August 19, 2009 at 1:55 pm
This article has been viewed 63940 time(s).